SCHEMBL5813428

SCHEMBL5813428

Fc1cccc(-c2nc(N3CCCCC3)sc2-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.50
KCNH2 Q12809 2/20 0.49
MAPK10 P53779 1/20 0.44
FYN P06241 1/20 0.43
RIPK2 O43353 1/20 0.43
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CCND3 P30281 1/20 0.42
CDK6 Q00534 1/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
DGAT1 O75907 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
MAPK14 Q16539 2/20 0.40
CCNB2 O95067 2/20 0.39
CDK1 P06493 2/20 0.39
CCNB1 P14635 2/20 0.39
CCNB3 Q8WWL7 2/20 0.39
MAPK13 O15264 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812981 1.00 BRAF (0.50) BRAFKCNH2MAPK10FYNRIPK2
SCHEMBL5816373 0.97 BRAF (0.53) BRAFKCNH2MAPK10FYNRIPK2
SCHEMBL5815392 0.93 BRAF (0.49) BRAFKCNH2FYNRIPK2CDK4
SCHEMBL5819038 0.93 BRAF (0.49) BRAFKCNH2MAPK10FYNRIPK2
SCHEMBL5814577 0.92 BRAF (0.50) BRAFKCNH2RIPK2CDK4CCND1
SCHEMBL5812160 0.92 KCNH2 (0.55) BRAFKCNH2RIPK2CDK4CCND1
SCHEMBL5818887 0.92 BRAF (0.50) BRAFKCNH2MAPK10FYNRIPK2
SCHEMBL5819465 0.89 MAPK14 (0.51) BRAFKCNH2MAPK10RIPK2CDK4
SCHEMBL5813731 0.89 ADORA1 (0.49) BRAFKCNH2MAPK10CDK4CCND1
SCHEMBL5819447 0.89 ADORA1 (0.49) BRAFKCNH2MAPK10CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed